Valuation: InMode Ltd.

Market Cap 878M 770M 714M 656M 1.24B 84.06B 1.27B 8.5B 3.34B 41.28B 3.3B 3.23B 143B P/E 2026 *
13.3x
P/E 2027 * 11.9x
Enterprise Value 878M 770M 714M 656M 1.24B 84.06B 1.27B 8.5B 3.34B 41.28B 3.3B 3.23B 143B EV / Sales 2026 *
2.37x
EV / Sales 2027 * 2.32x
Free-Float
60.55%
Yield 2026 *
-
Yield 2027 * -
1 day-0.43%
1 week+4.49%
Current month+4.34%
1 month+12.42%
3 months+9.04%
6 months+8.73%
Current year+3.85%
1 week 14.4
Extreme 14.4
15.37
1 month 13.21
Extreme 13.21
15.37
Current year 12.72
Extreme 12.72
16.67
1 year 12.72
Extreme 12.72
16.74
3 years 12.72
Extreme 12.72
48.25
5 years 12.72
Extreme 12.72
99.27
10 years 6.53
Extreme 6.53
99.27
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 02/01/2008
Chief Executive Officer 73 02/01/2008
Director of Finance/CFO 41 19/05/2026
Director TitleAgeSince
Chairman 73 02/01/2008
Director/Board Member 59 07/08/2019
Chairman 67 05/05/2026
Date Insider Type Main position Quantity % Market Cap.
05-19Other

Chairman

0 0%
05-19Other

Chief Financial Officer

26,733 0.0422%
03-18Other

Chairman

10,000 0.0158%
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%+4.49%+3.49%-66.24% 878M
+0.54%+2.33%+24.53%+0.57% 196B
+0.83%-5.38%-20.70%+18.03% 144B
+0.61%+3.38%+1.22%-16.19% 141B
+0.13%+0.50%-57.04%-15.09% 66.54B
-0.46%-3.54%+17.28%-1.37% 53.09B
+2.80%+1.95%-22.68%-30.55% 44.12B
-0.84%+1.92%+10.85%+11.53% 37.93B
-1.04%-1.71%+22.43%+38.30% 36.96B
+1.11%+0.83%-12.18%-19.68% 29.43B
Average +0.29%-0.35%-3.28%-8.07% 74.98B
Weighted average by Cap. +0.49%-0.82%-1.33%-1.04%

Financials

2026 *2027 *
Net sales 370M 325M 301M 277M 523M 35.42B 533M 3.58B 1.41B 17.39B 1.39B 1.36B 60.06B 379M 333M 308M 283M 536M 36.3B 547M 3.67B 1.44B 17.83B 1.42B 1.39B 61.57B
Net income 72.82M 63.87M 59.15M 54.43M 103M 6.97B 105M 705M 277M 3.42B 273M 267M 11.82B 78.85M 69.16M 64.05M 58.93M 111M 7.55B 114M 763M 299M 3.71B 296M 290M 12.8B
Net Debt - -
Logo InMode Ltd.
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Employees
660
Date Price Change Volume
13/07/26 $15.26 -0.16% 393,806
10/07/26 $15.28 +1.80% 823,376
09/07/26 $15.01 +3.80% 1,684,399
08/07/26 $14.46 -0.55% 450,401
07/07/26 $14.54 -0.41% 409,944
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
15.28USD
Average target price
14.33USD
Spread / Average Target
-6.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INMD Stock